+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Global Biosurgery Market Report and Forecast 2024-2032

  • PDF Icon

    Report

  • 140 Pages
  • April 2024
  • Region: Global
  • Expert Market Research
  • ID: 5797872

Global Biosurgery Market Overview

The global biosurgery market was valued at USD 14.83 billion in 2023, growing at a compound annual growth rate (CAGR) of 7.47% during the forecast period and expected to attain a value of USD 28.86 billion by 2032.

Biosurgery is a branch of medical science that involves the use of biological materials, such as hemostats, sealants, adhesives, bone grafts, soft tissue patches and matrices, to enhance the healing process, prevent excessive bleeding, seal leaks and repair damaged tissues and bones. Biosurgery products are widely used in various surgical procedures, such as cardiovascular, orthopedic, neurosurgery, general surgery, gynecology, urology, and ophthalmology.

The global biosurgery market has been characterized by dynamic growth, driven by technological innovations, an aging global population, and an increase in the prevalence of chronic diseases that require surgical interventions. The market's expansion is also fueled by the growing demand for effective wound closure and surgical recovery solutions, which are critical for improving patient outcomes and reducing hospital stays.

Global Biosurgery Market Drivers and Constraints

The major factors driving the growth of the global biosurgery market are:

  • The increasing prevalence of chronic diseases, such as diabetes, cancer, cardiovascular disorders, and osteoporosis, that require surgical interventions.
  • The rising geriatric population and the associated increase in the incidence of age-related disorders, such as arthritis, cataract, and Alzheimer's.
  • The growing demand for minimally invasive surgeries and the adoption of advanced technologies, such as robotics, nanotechnology, and bioprinting, that enhance the efficacy and safety of biosurgery products.
  • The rising awareness and acceptance of biosurgery products among surgeons and patients, especially in emerging markets, such as China, India, Brazil, and South Africa.
  • The increasing investments and funding by governments and private organizations in the research and development of biosurgery products.

The major factors restraining the growth of the global biosurgery market are:

  • The high cost and low reimbursement of biosurgery products, especially in developing and underdeveloped countries.
  • Stringent regulatory policies and approval processes for biosurgery products in various regions.
  • The risk of adverse reactions, infections, and immune responses associated with the use of biosurgery products.
  • The lack of skilled and trained professionals and the limited availability of biosurgery products in some regions.

Global Biosurgery Market Trends and Developments

The global biosurgery market is witnessing several trends and developments that are expected to shape its future growth and opportunities. Some of the key trends and developments are:

Technological Advancements: Innovations in biomaterials and surgical techniques are enhancing the effectiveness of biosurgery products. For example, the development of advanced hemostatic agents, sealants, and adhesives that offer better control of bleeding and improved wound healing is driving market growth.

  • Growth in Minimally Invasive Surgeries: The increasing preference for minimally invasive surgeries (MIS) due to their advantages such as shorter hospital stays, less post-operative pain, and quicker recovery is boosting the demand for biosurgery products that are compatible with these procedures.
  • Rising Prevalence of Chronic Diseases: The growing incidence of chronic diseases such as cancer, cardiovascular diseases, and obesity is leading to a higher number of surgical interventions, thereby fueling the demand for biosurgery products.
  • Expansion in Emerging Markets: Emerging economies are witnessing a surge in healthcare expenditure, improved healthcare infrastructure, and a growing middle-class population. This is leading to increased adoption of advanced surgical procedures, including biosurgery, in these regions.
  • Regenerative Medicine: The field of regenerative medicine is expanding, with an increasing number of applications for biosurgery products in tissue engineering, stem cell therapy, and organ transplantation. This is expected to drive further growth in the market.
  • Stringent Regulatory Framework: The biosurgery market is subject to strict regulatory scrutiny, which can impact the approval and commercialization of new products. Companies are focusing on meeting regulatory standards to ensure market entry and acceptance.
  • Collaborations and Acquisitions: Strategic collaborations, mergers, and acquisitions among key players are common in the biosurgery market. These alliances are aimed at expanding product portfolios, entering new markets, and leveraging technological expertise.
  • Focus on Research and Development: Companies in the biosurgery market are investing heavily in research and development to innovate and develop new products that meet the evolving needs of the healthcare industry.

Global Biosurgery Market Segmentation

The global biosurgery market can be segmented based on product type, source, application, end-user and region.

Market Breakup by Product Type

  • Bone and Graft Substitutes
  • Soft-Tissue Attachments
  • Hemostatic Agents
  • Surgical Sealants and Adhesives
  • Adhesion Barriers
  • Staple Line Reinforcement

Market Breakup by Source

  • Biologics Products
  • Synthetic Products

Market Breakup by Application

  • Orthopedic Surgery
  • General Surgery
  • Neuro and1 Spine Surgery
  • Cardiovascular Surgery
  • Gynecological Surgery
  • Other Applications

Market Breakup by End User

  • Hospitals & Clinics
  • Surgical Centres
  • Others

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Global Biosurgery Market Competitive Landscape

The global biosurgery market is highly competitive and fragmented, with the presence of several key players and numerous local and regional players. Some of the major players operating in the market are Johnson & Johnson, Baxter International, Medtronic, BD, Integra Lifesciences, CSL, Sanofi, Atrium Medical, Cryolife, Hemostasis, Stryker, B. Braun, and Biom'up. These players are engaged in various strategies, such as mergers and acquisitions, product launches, collaborations, partnerships, and expansions, to gain a competitive edge and increase their market share.


This product will be delivered within 5-7 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Biosurgery Market Overview
3.1 Global Biosurgery Market Historical Value (2017-2023)
3.2 Global Biosurgery Market Forecast Value (2024-2032)
4 Global Biosurgery Market Landscape
4.1 Global Biosurgery Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Biosurgery Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Application
4.2.3 Analysis by End User
5 Global Biosurgery Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Biosurgery Market Segmentation
6.1 Global Biosurgery Market by Product
6.1.1 Market Overview
6.1.2 Bone-Graft Substitutes
6.1.3 Soft-Tissue Attachment
6.1.4 Haemostatic Agents
6.1.5 Surgical Sealants and Adhesives
6.1.6 Adhesion Barriers
6.1.7 Staple Line Reinforcement
6.2 Global Biosurgery Market by Application
6.2.1 Market Overview
6.2.2 Orthopaedic Surgery
6.2.3 General Surgery
6.2.4 Neurological Surgery
6.2.5 Cardiovascular Surgery
6.2.6 Gynaecological Surgery
6.2.7 Others
6.3 Global Biosurgery Market by End User
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Clinics
6.3.4 Others
6.4 Global Biosurgery Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Biosurgery Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Biosurgery Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Biosurgery Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Biosurgery Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Biosurgery Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Baxter
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 BD
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Johnson & Johnson Services, Inc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Medtronic
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 B. Braun Melsungen AG
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 CryoLife, Inc.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Stryker Corporation
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Integra LifeSciences Corporation
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Hemostasis, LLC
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 CSL Limited
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 AROA BIOSURGERY LIMITED
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 TELA Bio, Inc.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Tissue Regenix
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Osiris Therapeutics, Inc.
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
18 Global Biosurgery Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.

Companies Mentioned

  • Baxter
  • BD
  • Johnson & Johnson Services Inc.
  • Medtronic
  • B. Braun Melsungen AG
  • CryoLife Inc.
  • Stryker Corporation
  • Integra LifeSciences Corporation
  • Hemostasis LLC
  • CSL Limited
  • AROA BIOSURGERY LIMITED
  • TELA Bio Inc.
  • Tissue Regenix
  • Osiris Therapeutics Inc.

Methodology

Loading
LOADING...